SonoThera

“SonoThera — Ultrasound-mediated nonviral genetic medicine platform. Raised $125M Series B from a syndicate including J&J, ARK, Leaps by Bayer, RA Capital.”

“The breadth of strategic and financial investors — spanning pharma, genomics, and crossover funds — suggests nonviral delivery (avoiding the immune challenges of viral vectors) is approaching a critical validation inflection point.”

“SonoThera, an SF-based developer of ultrasound-delivered genetic medicines, raised $125m in Series B funding.”

“SonoThera, an SF-based developer of ultrasound-delivered genetic medicines, raised $125m in Series B funding.”